Among oncogenic networks implicated in CRC, the PI3K/AKT/mTOR (PAM) axis is one of the most frequently dysregulated pathways in several cancers, contributing to tumor growth, metastasis, and poor response to treatment11. This evidence concerns the gene AKT1 and neoplasm.